| Basics |
| Company: |
Tenaya Therapeutics, Inc. |
| IPO Date: |
June 30, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$87.93M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.32 | 4.60%
|
| Avg Daily Range (30 D): |
$0.05 | 4.26%
|
| Avg Daily Range (90 D): |
$0.12 | 5.89%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.61M |
| Avg Daily Volume (30 D): |
1.75M |
| Avg Daily Volume (90 D): |
3.56M |
| Trade Size |
| Avg Trade Size (Sh.): |
176 |
| Avg Trade Size (Sh.) (30 D): |
390 |
| Avg Trade Size (Sh.) (90 D): |
297 |
| Institutional Trades |
| Total Inst.Trades: |
98 |
| Avg Inst. Trade: |
$1.68M |
| Avg Inst. Trade (30 D): |
$.77M |
| Avg Inst. Trade (90 D): |
$.93M |
| Avg Inst. Trade Volume: |
.28M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.26M |
| Avg Closing Trade (30 D): |
$.9M |
| Avg Closing Trade (90 D): |
$1.71M |
| Avg Closing Volume: |
420.05K |
|
|
|
|
| News |
Jun 27, 2024 @ 9:00 PM
Tenaya Therapeutics Announces Research Leadership ...
Source: Tenaya Therapeutics, Inc.
|
Jun 18, 2024 @ 8:30 PM
Tenaya Therapeutics to Participate at the TD Cowen...
Source: Tenaya Therapeutics, Inc.
|
May 14, 2024 @ 8:05 PM
Tenaya Therapeutics Reports First Quarter 2024 Fin...
Source: Tenaya Therapeutics, Inc.
|
May 2, 2024 @ 9:00 PM
Tenaya Therapeutics to Highlight Growing Capabilit...
Source: Tenaya Therapeutics, Inc.
|
Mar 18, 2024 @ 8:05 PM
Tenaya Therapeutics Reports Fourth Quarter and Ful...
Source: Tenaya Therapeutics, Inc.
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-1.44
|
$-.3
|
$-.34
|
|
Diluted EPS
|
$-1.44
|
$-.3
|
$-.34
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -117.23M
|
$ -25.63M
|
$ -29.43M
|
|
Operating Income / Loss
|
$ -122.74M
|
$ -26.71M
|
$ -30.82M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -74.19M
|
$ -49.9M
|
$ -1.43M
|
|
PE Ratio
|
|
|
|
|
